CN1837205A - 吡唑并[4,3－c]吡啶－3－酮L－酒石酸盐的制备方法 - Google Patents
吡唑并[4,3－c]吡啶－3－酮L－酒石酸盐的制备方法 Download PDFInfo
- Publication number
- CN1837205A CN1837205A CNA200610073385XA CN200610073385A CN1837205A CN 1837205 A CN1837205 A CN 1837205A CN A200610073385X A CNA200610073385X A CN A200610073385XA CN 200610073385 A CN200610073385 A CN 200610073385A CN 1837205 A CN1837205 A CN 1837205A
- Authority
- CN
- China
- Prior art keywords
- methyl
- oxygen
- general formula
- pyridine
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Physical Education & Sports Medicine (AREA)
- Crystallography & Structural Chemistry (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyridine Compounds (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12274599P | 1999-02-26 | 1999-02-26 | |
| US60/122,745 | 1999-02-26 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA031075525A Division CN1515570A (zh) | 1999-02-26 | 2000-02-25 | 吡唑并[4,3-c]吡啶-3-酮L-酒石酸盐的制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1837205A true CN1837205A (zh) | 2006-09-27 |
Family
ID=22404505
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB001053884A Expired - Lifetime CN1137891C (zh) | 1999-02-26 | 2000-02-25 | 生长激素促分泌素的制备方法 |
| CNA200610073385XA Pending CN1837205A (zh) | 1999-02-26 | 2000-02-25 | 吡唑并[4,3－c]吡啶－3－酮L－酒石酸盐的制备方法 |
| CNA031075525A Pending CN1515570A (zh) | 1999-02-26 | 2000-02-25 | 吡唑并[4,3-c]吡啶-3-酮L-酒石酸盐的制备方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB001053884A Expired - Lifetime CN1137891C (zh) | 1999-02-26 | 2000-02-25 | 生长激素促分泌素的制备方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA031075525A Pending CN1515570A (zh) | 1999-02-26 | 2000-02-25 | 吡唑并[4,3-c]吡啶-3-酮L-酒石酸盐的制备方法 |
Country Status (44)
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109320515A (zh) * | 2018-11-22 | 2019-02-12 | 常州大学 | 一种Capromorelin手性中间体的不对称合成方法 |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1132388A3 (en) * | 2000-03-09 | 2004-03-03 | Pfizer Products Inc. | Hexahydropyrazolo[4,3-c]pyridine metabolites |
| JP2003534377A (ja) | 2000-05-30 | 2003-11-18 | メルク エンド カムパニー インコーポレーテッド | メラノコルチン受容体作働薬 |
| AU2003237595A1 (en) * | 2003-05-26 | 2004-12-13 | Biocon Limited | Process for the preparation of s(+)-2-ethoxy-4-(n-{1-(2-piperidinophelyl)-3-methyl-1- butyl} aminocarbonylmethyl)benzoic acid derivatives |
| WO2005027913A1 (en) * | 2003-09-19 | 2005-03-31 | Pfizer Products Inc. | Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and a growth hormone secretagogue |
| US9117477B2 (en) | 2013-05-08 | 2015-08-25 | HGST Netherlands B.V. | Perpendicular magnetic recording media having novel seed layer |
| MX360906B (es) * | 2013-05-28 | 2018-11-21 | Raqualia Pharma Inc | Forma cristalina del l-tartrato de 2-amino-n[2-(3a-(r)- bencil-2-metil-3-oxo-2,3,3a,4,6,7-hexahidro-pirazolo[4,3-c]piridi n-5-il)-1-(r)-benciloximetil-2-oxo-etil]-isobutiramida. |
| WO2024217441A1 (zh) * | 2023-04-21 | 2024-10-24 | 长春金赛药业有限责任公司 | GHSR 1a激动剂、药物组合物及其制备方法和应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8610980D0 (en) | 1986-05-06 | 1986-06-11 | Ici America Inc | Heterocyclic fused tricyclic compounds |
| GB8901423D0 (en) | 1989-01-23 | 1989-03-15 | Fujisawa Pharmaceutical Co | Pyrazolopyridine compound and processes for preparation thereof |
| US5578593A (en) | 1992-12-11 | 1996-11-26 | Merck & Co., Inc. | Spiro piperidines and homologs promote release of growth hormone |
| HUT74733A (en) | 1993-11-09 | 1997-02-28 | Merck & Co Inc | Piperidines, pyrrolidines and hexahydro-1h-azepines promote release of growth hormone |
| US5609150A (en) | 1995-04-18 | 1997-03-11 | Maged; Jeffrey M. | Method for dilating respiratory passages |
| TW432073B (en) | 1995-12-28 | 2001-05-01 | Pfizer | Pyrazolopyridine compounds |
| WO1997034604A1 (en) | 1996-03-21 | 1997-09-25 | Merck & Co., Inc. | 4-spiroindoline piperidines promote release of growth hormone |
| WO1997036873A1 (en) | 1996-04-03 | 1997-10-09 | Merck & Co., Inc. | Piperidines, pyrrolidines and hexahydro-1h-azepines promote release of growth hormone |
| EP1001970B1 (en) | 1997-06-25 | 2007-03-07 | Pfizer Inc. | Dipeptide derivatives as growth hormone secretagogues |
| UA53716C2 (uk) | 1997-06-25 | 2003-02-17 | Пфайзер Продактс Інк. | Тартратна сіль заміщеного дипептиду, спосіб її одержання, проміжні сполуки та спосіб їх одержання, фармацевтична композиція (варіанти), спосіб підвищення рівнів ендогенного гормону росту та спосіб лікування або профілактики захворювань (варіанти) |
| UA64751C2 (uk) * | 1997-06-25 | 2004-03-15 | Пфайзер Продактс Інк. | Спосіб лікування інсулінової толерантності речовинами, які посилюють секрецію гормону росту (варіанти) та фармацевтична композиція (варіанти) |
-
2000
- 2000-02-01 US US09/496,075 patent/US6541634B2/en not_active Expired - Lifetime
- 2000-02-16 SG SG200000835A patent/SG90096A1/en unknown
- 2000-02-17 IL IL134599A patent/IL134599A/en not_active IP Right Cessation
- 2000-02-17 IL IL157103A patent/IL157103A/en not_active IP Right Cessation
- 2000-02-18 IS IS5380A patent/IS5380A/is unknown
- 2000-02-21 SK SK230-2000A patent/SK284982B6/sk not_active IP Right Cessation
- 2000-02-21 IN IN138DE2000 patent/IN192352B/en unknown
- 2000-02-21 HN HN2000000021A patent/HN2000000021A/es unknown
- 2000-02-22 TW TW095134050A patent/TW200718702A/zh unknown
- 2000-02-22 BG BG104175A patent/BG104175A/bg unknown
- 2000-02-22 TW TW089103014A patent/TWI286142B/zh not_active IP Right Cessation
- 2000-02-23 DZ DZ000037A patent/DZ3018A1/xx active
- 2000-02-23 CO CO00012732A patent/CO5160252A1/es unknown
- 2000-02-23 TN TNTNSN00035A patent/TNSN00035A1/fr unknown
- 2000-02-23 PE PE2000000148A patent/PE20001550A1/es not_active Application Discontinuation
- 2000-02-23 GT GT200000018A patent/GT200000018A/es unknown
- 2000-02-23 MA MA25911A patent/MA25072A1/fr unknown
- 2000-02-23 OA OA1200000050A patent/OA11325A/en unknown
- 2000-02-23 ZA ZA200000888A patent/ZA200000888B/xx unknown
- 2000-02-24 UA UA2000021098A patent/UA70306C2/uk unknown
- 2000-02-24 CA CA2299495A patent/CA2299495C/en not_active Expired - Lifetime
- 2000-02-24 JP JP2000047626A patent/JP3437813B2/ja not_active Expired - Lifetime
- 2000-02-24 AP APAP/P/2000/001754A patent/AP1221A/en active
- 2000-02-24 AU AU19471/00A patent/AU764122B2/en not_active Ceased
- 2000-02-24 PA PA20008491201A patent/PA8491201A1/es unknown
- 2000-02-24 AR ARP000100784A patent/AR029617A1/es active IP Right Grant
- 2000-02-24 ID IDP20000134D patent/ID24861A/id unknown
- 2000-02-25 PT PT00301526T patent/PT1031575E/pt unknown
- 2000-02-25 NZ NZ503062A patent/NZ503062A/en unknown
- 2000-02-25 KR KR10-2000-0009296A patent/KR100372063B1/ko active IP Right Grant
- 2000-02-25 EP EP04009914A patent/EP1449842A1/en not_active Withdrawn
- 2000-02-25 CN CNB001053884A patent/CN1137891C/zh not_active Expired - Lifetime
- 2000-02-25 CN CNA200610073385XA patent/CN1837205A/zh active Pending
- 2000-02-25 TR TR2000/00536A patent/TR200000536A2/xx unknown
- 2000-02-25 ES ES00301526T patent/ES2226712T3/es not_active Expired - Lifetime
- 2000-02-25 DK DK00301526T patent/DK1031575T3/da active
- 2000-02-25 NO NO20000965A patent/NO20000965L/no not_active Application Discontinuation
- 2000-02-25 EA EA200000172A patent/EA003218B1/ru not_active IP Right Cessation
- 2000-02-25 AT AT00301526T patent/ATE277944T1/de not_active IP Right Cessation
- 2000-02-25 DE DE60014212T patent/DE60014212T2/de not_active Expired - Lifetime
- 2000-02-25 HU HU0000907A patent/HUP0000907A3/hu unknown
- 2000-02-25 PL PL00338628A patent/PL338628A1/xx not_active IP Right Cessation
- 2000-02-25 EP EP00301526A patent/EP1031575B1/en not_active Expired - Lifetime
- 2000-02-25 SI SI200030502T patent/SI1031575T1/xx unknown
- 2000-02-25 CN CNA031075525A patent/CN1515570A/zh active Pending
- 2000-02-25 HR HR20000103A patent/HRP20000103A2/hr not_active Application Discontinuation
- 2000-02-28 BR BRPI0000967A patent/BRPI0000967B8/pt not_active IP Right Cessation
- 2000-02-28 BR BRPI0017522A patent/BRPI0017522B8/pt not_active IP Right Cessation
- 2000-02-28 EE EEP200000193A patent/EE200000193A/xx unknown
-
2001
- 2001-02-21 HK HK01101247A patent/HK1030219A1/xx not_active IP Right Cessation
-
2002
- 2002-07-20 KR KR1020020042729A patent/KR100361783B1/ko active IP Right Grant
- 2002-10-30 US US10/283,720 patent/US6673929B2/en not_active Expired - Lifetime
-
2003
- 2003-04-04 JP JP2003101688A patent/JP4051314B2/ja not_active Expired - Lifetime
- 2003-04-04 JP JP2003101700A patent/JP2003261565A/ja active Pending
-
2006
- 2006-05-05 AR ARP060101825A patent/AR053722A2/es active IP Right Grant
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109320515A (zh) * | 2018-11-22 | 2019-02-12 | 常州大学 | 一种Capromorelin手性中间体的不对称合成方法 |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1231478C (zh) | 光学活性的哌啶中间体的制备方法和该中间体 | |
| CN1273451C (zh) | 哌啶mch拮抗剂及其治疗肥胖症的用途 | |
| CN1041830C (zh) | 肽化合物 | |
| CN1040985C (zh) | 苯并氮杂䓬类化合物的制备方法 | |
| CN1372566A (zh) | 抗细小核糖核酸病毒的化合物和组合物,它们的药物用途,及其合成原料 | |
| CN101076515A (zh) | 制备3－吡咯烷－2－基－丙酸衍生物的新方法 | |
| CN1759093A (zh) | 用于制备1,2－二氨基化合物的不使用叠氮化物的方法 | |
| CN1240380C (zh) | 吲哚并吡咯并咔唑的相转移催化苷化方法 | |
| CN1612857A (zh) | 含香叶基的化合物 | |
| CN1137891C (zh) | 生长激素促分泌素的制备方法 | |
| CN1039910C (zh) | 雪花胺衍生物、其制备方法及其作为药物的用途 | |
| CN1082964C (zh) | 手性的双膦类化合物 | |
| CN1628087A (zh) | 链烯酮的制备方法 | |
| CN1144783C (zh) | 前列腺素衍生物 | |
| CN1043042C (zh) | 7－[2－(2－氨基噻唑－4－基)－2－(Z)－羟亚胺基－乙酰胺基]－3－(甲氧甲基)－3－头孢烯－4－羧酸－α－(2,2－二甲基丙酰氧)乙酯拆分的方法 | |
| CN1132511A (zh) | 基质金属蛋白酶抑制剂 | |
| CN1255498A (zh) | 生长激素促分泌剂的制备方法和中间体 | |
| CN1849320A (zh) | 制备伦扎必利及其中间体的方法 | |
| CN1194960C (zh) | 4,5－二氨基莽草酸衍生物的制备方法 | |
| CN1261428C (zh) | 用于生产海绵内酯和海绵内酯类似物的中间体的制备方法 | |
| CN1025334C (zh) | 新的谷氨酸衍生物的制备方法 | |
| CN1696151A (zh) | 一种法氏囊素三肽合成方法 | |
| CN1138850A (zh) | 制备对映体纯环戊烷-和环戊烯-β-氨基酸的新型高对映体选择性方法 | |
| CN1139599C (zh) | N-(1(s)-乙氧羰基-3-苯丙基)-l-丙氨酰基-氨基酸药理上可接受的盐的制备方法 | |
| CN1617881A (zh) | 化学方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1091483 Country of ref document: HK |
|
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1091483 Country of ref document: HK |